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AbstRACt
Objective: The study aim was to determine the hemoglobin genotypic and allelic distributions in fetal population, and to 
quantitatively evaluate the effect of heterozygous maternal DNA contamination of homozygous fetal DNA in chorionic villi, 
on fetal hemoglobin genotypes.
Materials and Methods: A descriptive, cross sectional study of amplification refractory mutation system-polymerase 
chain reaction (ARMS-PCR) analysis of fetal hemoglobin genotype using DNA from chorionic villi and maternal venous 
blood. The primary fetal hemoglobin genotypes were obtained in the first phase and the secondary hemoglobin 
genotypes after contaminating homozygous primary genotypes (HbAHbA and HbSHbS) with varying proportions of 
heterozygous maternal DNA (HbAHbS). Data analysis was done with Micosoft Excel 2010 statistical package and 
Chi-square (goodness-of-fit).
Results: There was no statistically significant deviation in the hemoglobin genotypic and allelic counts between the observed 
and the expected counts in the fetal population based on Mendelian expectation. Contaminating homozygous fetal DNA 
with >11.1%  (0.5 µl) of heterozygous maternal DNA produced significant change  in  fetal hemoglobin genotype  results. 
Homozygous hemoglobin genotypes HbAHbA were affected more than HbSHbS.
Conclusion: Study established Mendelian distribution in the fetal population and the levels of heterozygous maternal 
contamination of homozygous fetal DNA that resulted in significant risk of misdiagnosis.
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Introduction
Sickle cell anemia (SCA) is a common single gene defect in 
sub-Saharan Africa, India, Saudi Arabia, and Mediterranean 
countries and also the first molecular disease diagnosed 
through the application of molecular techniques.[1-3] It is an 
autosomal recessive condition that most commonly follows 
mating between heterozygous couples and less commonly 
after mating between homozygous and heterozygous 
couple. The distribution in the fetal population is expectedly 
Mendelian. The gold standard for early prenatal diagnosis 
is chorionic villous sampling (CVS) for molecular diagnosis 
with polymerase chain reaction (PCR) based technique.[4] 
The sample consists of fetal cells in chorionic villi that are 
potentially contaminated with maternal decidua and blood. 
Complete separation of cells and DNA of chorionic villi 
origin from those of maternal decidua remains a challenge, 
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because of the anatomical relationship between the 
maternal decidua and the chorionic villi. This contributes 
significantly to prenatal misdiagnosis of SCA, particularly 
with PCR-based protocols that amplify DNA.[5,6] Misdiagnosis 
due to co-amplification of maternal HbAHbS DNA sequences 
is of serious medical and genetic consequence, especially, 
with homozygous fetal hemoglobin genotype (HbAHbA and 
HbSHbS) that may be misreported as heterozygous (HbAHbS) 
fetal hemoglobin genotype.[5-7]
The aim of the study was to determine the fetal hemoglobin 
genotypes distribution in early pregnancy and the quantitative 
effect of maternal DNA contamination of homozygous fetal 
DNA on hemoglobin genotype result.
Materials and Methods
This was a descriptive cross sectional study of controlled 
molecular laboratory experiment designed to determine 
the fetal hemoglobin genotypes distribution and evaluates 
the quantitative effect of heterozygous maternal DNA 
contamination of homozygous fetal DNA obtained from 
chorionic villi sample.
Participants and approval
The study ethical approval was obtained from the Human 
Ethics and Research Committee of the Olabisi Onabanjo 
University Teaching Hospital, Sagamu, Ogun State. The 
subjects were pregnant women attending antenatal clinics in 
Olabisi Onabanjo University Teaching Hospital, Sagamu, while 
subject samples were the chorionic villi that were analyzed at 
the molecular laboratory units of department of Cell Biology 
and Genetics, University of Lagos and High Rocks Fetal 
Medicine and Genetic Diagnosis Center. Lagos non-directional 
counseling was provided and signed informed consent was 
obtained from the pregnant women between 11+0 weeks and 
13+6 weeks. Seventy six pregnancies were studied based on 
Cochran formula for determination of sample size.[8]
Chorionic villous sampling and sample dissection
Transabdominal CVS using aspiration method was used to 
obtain sample. The aspirated chorionic villi were dissected 
free of maternal contaminants and further examined under 
inverted microscope to ensure complete dissection of 
maternal decidua contaminant [Figure 1].
DNA extraction and assessment
DNA was extracted from 5 mg to 15 mg of chorionic villi and 
0.5 ml of parental venous blood using modification of boiling 
methods.[9] DNA was assessed using NanoDrop (ND-1000) 
spectrophotometer. The A260/280 was used to assess the purity 
of DNA and >1.8 was considered satisfactory. The A260 was 
used to determine concentration. Samples for analysis 
were >50 ng/µl.
Amplification refractory mutation system‑polymerase 
chain reaction analysis
The molecular analysis was done using modification 
o f  ARMS -PCR  p ro t oc o l  de sc r i bed  by  Newton 
et al.[10] The PCR MasterMix was prepared with PCR mix 
{deoxynucleotides (dNTPs), distilled water (dH2O), MgCl2, 
10X buffer}, ARMS Primers {Forward (Mutant & Normal) and 
Reverse (Common C)}, and Taq DNA polymerase enzyme. 
The forward primers contains 30 nucleotide base each 
(HbS M: 5’- CCC ACA GGG CAG TAA CGG CAG ACT TCT 
GCA-3: and HbS N: 5’ CCC ACA GGG CAG TAA CGG CAG 
ACT TCT GCT-3’) while the reverse primer has 20 nucleotide 
base (HbS Com C: 5’-ACC TCA CCC TGT GGA GCC AC-3’). The 
PCR products were loaded into 16 gel wells representing 8 
reactions. The first three reactions were positive controls 
which were confirmed HbSHbS, HbAHbS, and HbAHbA 
genotypes respectively. The positive controls served as 
internal controls to confirm the optimum workings of the 
PCR. The next two reactions are parental samples previously 
confirmed as HbAHbS genotypes. The following two reactions 
are fetal samples of unknown hemoglobin genotypes, while 
the last reaction is the negative control. The negative control 
was to rule out contamination.
The secondary fetal hemoglobin genotypes that were 
obtained after heterozygous maternal DNA contamination 
of homozygous fetal sample were determined in the 
second phase. Each reaction was made up of positive 
controls (HbAHbA, HbAHbS, and HbSHbS), maternally 
contaminated homozygous fetal DNA , 0% (0.00 µl), 5.9% (0.25 
µl), 11.1% (0.50 µl), 15.8% (0.75 µl), and 20.0% (1.00 µl) 
respectively and the negative control. The PCR programme 
used was 28 cycles of denaturation (93°C/3 minutes), 
annealing (67°C/1 minute), and extension (72°C/1 minute).
Figure 1: Dissected chorionic villi
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Gel documentation/ultraviolet transillumination
PCR products were electrophoresed in a 1% agarose gel 
stained with ethidium bromide and the gel was visualized 
using the ultraviolet light filter on the Gel Imager (Alpha 
innotech 3400).
Data management and analysis
Data was analyzed with Microsoft Excel 2010 statistical 
software package. The statistical significance between 
observed and expected values was evaluated with 
χ2 (goodness-of-fit) test and result considered significant 
at P < 0.05. Degree of freedom (df0.05) = number of 
genotypes – number of alleles. The observed hemoglobin 
genotypes in the study population were derived from counts 
before maternal contamination (primary fetal hemoglobin 
genotypes) and after maternal contamination (secondary fetal 
hemoglobin genotypes). The observed count of primary and 
secondary fetal hemoglobin genotypes at each proportion 
of maternal DNA contamination were counted and statistical 
significance of the change in genotype observed was assessed 
with χ2, at P < 0.05.
Results
The gel images of hemoglobin genotypes (HbAHbA, HbAHbS, 
and HbSHbS), observed under ultraviolet transillumination 
are shown in Figure 2a, b, and c, respectively. In each sample 
analyzed, the hemoglobin genotype is shown by the presence 
of band in the left pair of a gel well (mutant allele), both left 
and right pair of gel well (mutant and normal allele) or right 
pair of the gel well (normal allele).
The observed and expected hemoglobin genotype 
distributions based on the Mendelian ratio from heterozygous 
mating in Table 1a, shows that the observed count (13) of 
HbSHbS was lower than the expected count of 19, while 
observed counts of both HbAHbA (22), and HbAHbS (41) 
were above the expected counts of 19 and 38 respectively. 
These differences in distribution are; however, not statistically 
significant (P = 0.26). The distributions of the two alleles 
responsible for the genotypes are shown in Table 1b. The 
observed allelic counts were higher for HbS (85) and lower 
for HbS (67) compared with the expected counts of 76 
based on Mendelian principle. Chi-square analysis shows 
statistically insignificant difference (P = 0.18). Table 1b shows 
the genotypic and allelic frequencies in the fetal population. 
The frequency of HbA allele is higher (0.56) than the expected 
while that of HbS (0.44) lower than the expected frequency 
of (0.50) based on Mendelian principle. The frequencies of 
HbAHbA (0.29) and HbAHbA (0.54) were more, while that of 
HbSHbS (0.17) less than the expected frequencies based on 
Mendelian principle.
The outcome of contaminating fixed amount of fetal 
DNA with varying proportions of heterozygous maternal 
Figure 2: Ultraviolet Documentation of Gel Images of Primary haemoglobin 
Genotypes. The positive controls samples in wells 1-6, were confirmed by the 
display of bands that implies the presence of an allele complementary to the 
specific primer in the reaction (right well lane band for HbSHbS, both wells 
lane bands for HbAHbS and left well lane band for HbAHbA). The parental 
samples in wells 7-10 show bands in the lanes of both pairs of well, confirming 
HbAHbS. (a) Fetal sample in gel wells 11-14 reveals bands in the lanes of only 
the left wells containing mutant primer as confirmation HbSHbS. Absence of 
band from the lanes of wells 15 and 16 rules out contamination. (b) foetal 
sample in gel wells 11-14 reveal bands in the lanes of the right and left wells 
containing mutant and normal primers respectively, as confirmation HbAHbS 
samples. Absence of bands in lanes of gel wells 15 and 16 ruled out DNA 
contamination. (c) Fetal sample in gel wells 11-14 reveals bands in the lanes 
of right tubes containing normal primers, as confirmation HbAHbA samples. 




Table 1: Foetal haemoglobin genotypic and allelic distribution 
and frequency
(a) Fetal haemoglobin genotypes and alleles distribution
Haemoglobin genotypes and allelic count
Haemoglobin HbAHbA HbAHbS HbSHbS Statistical 
significance
Observed counts 22 41 13 χ2=2.60
Expected counts 19 38 19 P=0.27
Allele HbA HbS
Observed counts 85 67 χ2=2.12
Expected counts 76 76 P=0.18
(b) The fetal genotypic and allelic frequencies
Alleles Genotypes
HbA HbS HbAHbA HbAHbS HbSHbS
Observed 0.56 0.44 0.29 0.54 0.17
Expected 0.50 0.50 0.25 0.50 0.25
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DNA on the 35 homozygous fetal hemoglobin genotypes 
(HbAHbA and HbSHbS) are shown in Tables 2a and 2b. With 
respect to HbAHbA samples [Table 2a], contaminating fetal 
DNA in chorionic villi sample with 5.9% (0.25 µl) of maternal 
DNA sample did not result in change of hemoglobin genotype 
result in any of the samples. Eight (36.4%) primary fetal 
hemoglobin genotype results changed, when fetal DNA sample 
was contaminated with 11.1% (0.5 µl) and 15.8% (0.75 µl) 
of maternal DNA sample, while 18 (82.3%) primary fetal 
hemoglobin genotype results changed when fetal DNA sample 
was contaminated with 20.0% (1.0 µl) of maternal DNA sample.
The results after heterozygous maternal DNA contamination of 
homozygous fetal DNA in respect of primary fetal hemoglobin 
genotype HbSHbS results were as follows [Table 2b]: There 
was no change observed in primary fetal hemoglobin 
genotype result when fetal DNA in chorionic villi sample was 
contaminated with 5.9% (0.25 µl) of maternal DNA sample. 
Two (11.1%) fetal primary fetal haemoglobin genotype results 
changed, when fetal DNA was contaminated with 11.1% 
(0.5 µl) and 15.8% (0.75 µl) respectively of maternal DNA, 
while eleven (84.6%) fetal primary fetal hemoglobin genotype 
results changed when foetal DNA in chorionic villi samples 
was contaminated with 20.0% (1.0 µl) of maternal DNA sample.
The statistical significance of the changes in primary 
homozygous fetal hemoglobin results are shown in 
Table 3a and b. The analysis confirms that all the changes 
observed, were statistically significant.
Discussion
Human hemoglobin polymorphism with respect to sickle cell 
anemia is of considerable interest in fetal medicine practice 
as well as in molecular genetics. The study observed that 
heterozygous maternal DNA contamination of 11.1% of 
homozygous fetal DNA in chorionic villi sample was sufficient 
to produce statistically significant change in the primary 
fetal hemoglobin genotype results. This is against the 30% 
maternal contamination previously reported using restriction 
fragment polymorphism (RFLP).[5] This finding confirms the 
fact that PCR-based protocol is relatively more sensitive to 
the presence of DNA in comparison with RFLP technique.
This study is the first report available to us in literature on 
the outcome of heterozygous maternal DNA contamination of 
homozygous fetal DNA on fetal hemoglobin genotype result 
using a PCR-based technique in Nigerian population. This 
can be explained by the fact that the ARMS-PCR technique 
for molecular identification of different mutations only 
became increasingly applied for molecular diagnosis of SCA 
especially in Nigeria. The possibility of misdiagnosis which 
was however first reported in 1986, was based on the use 
of RFLP technique and more recently reported to occur with 
the use of PCR based molecular protocol.[5,7,11]
This study finding is presented as a reliable and accurate 
data of primary fetal hemoglobin genotype because the 
extracted DNA were of high quality and also the molecular 
tool used (ARMS-PCR) is very sensitive to the presence of 
low proportions of DNA contamination. The observed fetal 
hemoglobin genotype distribution was not statistically different 
from expected distribution based on Mendelian principle. This 
could have implications for the understanding of the roles of 
possible selections pressures that operate during this gestational 
period. In particular, the heterozygous advantage for HbAHbS 
observed in the study population at this early gestation could be 
Table 2: Change in foetal haemoglobin genotype results after contaminating fixed (4.0 ul) foetal DNA with varying proportions of 
maternal DNA
(a) Change from HbAHbA to HbAHbS
Amount of Maternal DNA Sample (µl) Proportion of Maternal DNA Contamination 
of Foetal DNA in Chorionic Villi Sample (%)






(b) Change from HbSHbS to HbAHbS
Amount of Maternal DNA Sample (µl) Proportion of maternal DNA Contamination 
of Foetal DNA in Chorionic Villi Sample (%)
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postulated to be due to the effect of severe malaria parasitization 
from maternal blood and through the placenta barrier to the 
fetus. The possibility is further enhanced by the fact that malaria 
is endemic in the population, while the use of intermittent 
preventive treatment (IPTp) is not instituted at this gestational 
age.[3] In addition, the barrier function of the placenta appears 
to be most effective from the second trimester, thus leaving 
the fetus exposed in the first trimester, when sequestration of 
P. vivax in the placenta, has been demonstrated.[12,13]
The boiling protocol for DNA extraction and ARMS-PCR 
technique for molecular analysis has been shown in this study 
to be feasible methods that is appropriate, especially in low 
resource settings to produce satisfactory quality and quantity 
of DNA for prenatal diagnosis of SCA. Other studies have also 
shown their suitability for extracting DNA from small sample 
quantity such as the chorionic villi.[14-16]
The implication of the study finding is that a smaller 
proportion of heterozygous DNA contaminant is enough 
to produce significant change in homozygous primary DNA 
results. Although both groups of homozygous hemoglobin 
genotypes were affected, it is more pronounced in HbAHbA 
results, thus suggesting that a misdiagnosed HbAHbS result 
is more likely to have been HbAHbA instead of HbSHbS.
Conclusion
The study demonstrated the fetal hemoglobin genotypes 
distribution and also established the levels of heterozygous 
maternal contamination of homozygous fetal DNA that 
resulted in significant risk of misdiagnosis. The fetal 
hemoglobin genotype distribution is a justification for studies 
into the operations of selection pressures in‑utero, especially 
the preciserole of congenital malaria. The study would also 
stimulate awareness of the possibility of prenatal misdiagnosis 
and should justify researches into methods for reducing 
maternal contamination in fetal sample obtained from CVS.
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Table 3: Statistical analysis of changes in primary foetal 
haemoglobin genotypes










4.00+0.25 22 (100.0) (0)
4.00+0.50 14 (63.6) 8 (36.4) χ2=19.17
4.00+0.75 14 (63.6) 8 (36.4) P=0.0003
4.00+1.00 4 (18.8) 18 (1.2)










4.00+0.25 13 (100.0) (0)
4.00+0.50 11 (88.9) 2 (11.1) χ2=19.39
4.00+0.75 11 (88.9) 2 (11.1) P=0.0002
4.00+1.00 2 (15.4) 11 (84.6)
